A study of improvement effects on physical functions by ingesting a food ingredient.
- Conditions
- Elderly male/female subjects
- Registration Number
- JPRN-UMIN000047871
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
(1) Subjects who use affecting health foods routinely (over 3 times a week), and have any difficulty in stopping use after the consent. (2) Subjects who use the affecting medicines (International Standard as the 2022 Prohibited List of World Anti-Doping Code: anabolic agents, hormonal peptides, growth factors, beta2-agonists, and hormone/metabolism regulators), over 3 times a week, and have any difficulty in limiting use during this study. (3) Subjects who have a habit of resistance exercises with over moderate, or other ones with over high intensity. (4) Subjects who drink a lot of alcohol. (5) Subjects who have been suffered severely from their motor function (e.g., fracture, tendon rupture and tone muscle) within a year before this study. (6) Subjects with an impaired motor function. (7) Subjects who use implantable medical electronic devices, such as a pacemaker. (8) Subjects being prohibited from doing exercise, by a doctor. (9) Subjects with previous/present medical history of serious diseases in heart, liver, kidney, lung, digestive organs, blood, and endocrine/nervous/metabolic systems. (10) Subjects with drug and/or food allergy. (11) Subjects who are now under another clinical study with a medicine/food, or take part in that within 4 weeks before this study, or will join that after the consent to join this study. (12) Subjects who donated over 200 mL of their whole blood and/or blood components within a month before this study. (13) Males who donated over 400 mL of their whole blood within the last 3 months before this study. (14) Females who donated over 400 mL of their whole blood within the last 4 months before this study. (15) Males who will be collected over 1200 mL in total of their blood within 12 months, before and in this study. (16) Females who will be collected over 800 mL in total of their blood within 12 months, before and in this study. (17) Subjects who have been determined as ineligible for participation, by the principal/sub investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method